Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Smith

Showing results (131-140 of 166) with videos related to

Pageof 17
Sort By:
Women'S Health (London, England)|December 14, 2022
Homelessness in autistic women: Defining the research agendaGeorgia Lockwood Estrin, Victoria Aseervatham, Clara M De Barros, et al.
The Journal of Clinical Investigation|August 4, 2010
An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancerMichael A Morse, Amy C Hobeika, Takuya Osada, et al.
Cell|May 14, 2019
Cryo-EM Structure of Chikungunya Virus in Complex with the Mxra8 ReceptorKatherine Basore, Arthur S Kim, Christopher A Nelson, et al.
Journal for Immunotherapy of Cancer|November 12, 2020
Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratioErika J Crosby, Amy C Hobeika, Donna Niedzwiecki, et al.
Journal of the American Chemical Society|May 10, 2012
Rendering protein-based particles transiently insoluble for therapeutic applicationsJing Xu, Jin Wang, J Christopher Luft, et al.
Vaccine|September 10, 2020
The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of viral vector vaccinesRichard C Condit, Denny Kim, James S Robertson, et al.
Journal of Human Genetics|December 11, 2007
Association between four SNPs on chromosome 9p21 and myocardial infarction is replicated in an Italian populationGong-Qing Shen, Shaoqi Rao, Nicola Martinelli, et al.
Cancer Immunology, Immunotherapy : CII|April 11, 2012
Co-delivery of antigen and IL-12 by Venezuelan equine encephalitis virus replicon particles enhances antigen-specific immune responses and antitumor effectsTakuya Osada, Peter Berglund, Michael A Morse, et al.
The Lancet. Infectious Diseases|June 16, 2022
Safety and immunogenicity of PXVX0317, an aluminium hydroxide-adjuvanted chikungunya virus-like particle vaccine: a randomised, double-blind, parallel-group, phase 2 trialSean R Bennett, James M McCarty, Roshan Ramanathan, et al.
Development (Cambridge, England)|June 3, 2024
Insights into digit evolution from a fate map study of the forearm using Chameleon, a new transgenic chicken lineJulia Dong Hwa Oh, Lu Freem, Dillan D Z Saunders, et al.
Pageof 17

Showing results (131-140 of 166) with videos related to

Sort By:
Pageof 17
Women'S Health (London, England)|December 14, 2022
Homelessness in autistic women: Defining the research agendaGeorgia Lockwood Estrin, Victoria Aseervatham, Clara M De Barros, et al.
The Journal of Clinical Investigation|August 4, 2010
An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancerMichael A Morse, Amy C Hobeika, Takuya Osada, et al.
Cell|May 14, 2019
Cryo-EM Structure of Chikungunya Virus in Complex with the Mxra8 ReceptorKatherine Basore, Arthur S Kim, Christopher A Nelson, et al.
Journal for Immunotherapy of Cancer|November 12, 2020
Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratioErika J Crosby, Amy C Hobeika, Donna Niedzwiecki, et al.
Journal of the American Chemical Society|May 10, 2012
Rendering protein-based particles transiently insoluble for therapeutic applicationsJing Xu, Jin Wang, J Christopher Luft, et al.
Vaccine|September 10, 2020
The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of viral vector vaccinesRichard C Condit, Denny Kim, James S Robertson, et al.
Journal of Human Genetics|December 11, 2007
Association between four SNPs on chromosome 9p21 and myocardial infarction is replicated in an Italian populationGong-Qing Shen, Shaoqi Rao, Nicola Martinelli, et al.
Cancer Immunology, Immunotherapy : CII|April 11, 2012
Co-delivery of antigen and IL-12 by Venezuelan equine encephalitis virus replicon particles enhances antigen-specific immune responses and antitumor effectsTakuya Osada, Peter Berglund, Michael A Morse, et al.
The Lancet. Infectious Diseases|June 16, 2022
Safety and immunogenicity of PXVX0317, an aluminium hydroxide-adjuvanted chikungunya virus-like particle vaccine: a randomised, double-blind, parallel-group, phase 2 trialSean R Bennett, James M McCarty, Roshan Ramanathan, et al.
Development (Cambridge, England)|June 3, 2024
Insights into digit evolution from a fate map study of the forearm using Chameleon, a new transgenic chicken lineJulia Dong Hwa Oh, Lu Freem, Dillan D Z Saunders, et al.
Pageof 17